NCT04335110

Brief Summary

STELLA (Support via Technology Living and Learning with Advancing Alzheimer's disease and related dementias) is a multicomponent video-conference based intervention that aims to help family members caring for persons of dementia as well the person with dementia. The goal of this intervention is to reduce upsetting behaviors and care partner burden. Caring for a family member with Alzheimer's disease or related dementia (ADRD) can come with many burdens that affect not only the care partners' physical and psychological health but also barriers to access. Due to factors such as distance and cost, Internet-based interventions like STELLA are a great alternative to in-person interventions because it can still address the specific needs of families living with dementia. The hypothesis of this study is that care partners will show significant improvements in burden and depression following the intervention. STELLA is also designed to facilitate effective management of behavioral and psychological symptoms of dementia (BPSD). To accomplish this, up to 40 care partners and their 40 care recipients with Alzheimer's disease and related dementias will participate in an 8-week intervention with the support of a Guide (e.g. nurse or social worker). However, the primary focus of this study is on care partners. With the support of a Guide, care partners will identify strategies to address upsetting behaviors in the moderate to late stages of dementia. More specifically, a Guide will help care partners identify and modify distressing behavioral symptoms of dementia. Based on quantitative and qualitative approaches, the effect of the intervention on care partner affective symptoms, including depression and burden, as well as quality of life for both the care partner and the person with dementia will be assessed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 11, 2020

Completed
26 days until next milestone

First Posted

Study publicly available on registry

April 6, 2020

Completed
12 months until next milestone

Study Start

First participant enrolled

March 24, 2021

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2023

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2023

Completed
7 months until next milestone

Results Posted

Study results publicly available

January 23, 2024

Completed
Last Updated

January 23, 2024

Status Verified

December 1, 2023

Enrollment Period

2.2 years

First QC Date

March 11, 2020

Results QC Date

September 8, 2023

Last Update Submit

December 27, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Revised Memory and Behavior Problems Checklist

    Care recipient frequency of behaviors and caregiver reactions to behavioral symptoms. The scale measures how often a behavior occurs (Frequency, "F") and how much the caregiver reacts to it (Reactivity, "R"). Range for both scales is 0-96, lower scores are better. Subscales are not combined.

    The RMBPC is assessed 1 week prior to the 8-week intervention (pre), then 1 week after the intervention (post)

  • Center for Epidemiological Studies Depression Scale

    Caregiver depression symptoms, Range 0-30, lower scores indicate less depression (better). Depression is only measured for the caregivers, not the care recipients with dementia (only 1 group)

    1 week prior to the 8-week intervention (pre), then 1 week after the intervention (post)

Secondary Outcomes (5)

  • Desire to Institutionalize (DTI) Scale

    Measured at study entry only

  • Marwit Meuser Caregiver Grief Index

    1 week prior to the 8-week intervention (pre), then 1 week after the intervention (post)

  • Feasibility and Participant Acceptability

    Measured only once by caregivers 1 week after 8-week intervention

  • Quality of Life in Alzheimer's Disease (QOL-AD) Scale

    1 week prior to the 8-week intervention (pre), then 1 week after the intervention (post)

  • Sleep Duration

    Measures sleep from enrollment to study end. Mean sleep hours one week prior to intervention (pre) and one week after intervention (post). Measured in hours (units on a scale)

Study Arms (1)

Intervention

OTHER

Care Partners and Persons with Dementia. Up to 40 Care Partners and their 40 care-recipients with ADRD will participate in this study. The primary focus of this study is on Care Partners, however, we will gather subjective and objective data on participants with Alzheimer's Disease and Related Dementias (ADRD) to assess the effect of the intervention on Care Partner affective responses to caregiving and quality of life for both. STELLA participants will be recruited from the existing cohort of patients, and their Care Partners, who are enrolled in the Oregon Roybal Center for CAre Support Translational Research Advantaged by Integrating Technology) ORCASTRAIT Life Laboratory (OSLL).

Behavioral: STELLA (Support via TEchnology: Living and Learning with Advancing Alzheimer's disease and related dementias)

Interventions

STELLA consists of 8 sessions: 4 sessions one-to-one, with the Care Partner and a Guide, and then 4 sessions with one Guide with up to four Care Partners (total small group will include as few as two and as many as 4 Care Partners) Each weekly session takes about 1 hour. The first four sessions allow for development of the Care Partner-Guide working relationship. In these sessions, the Care Partners identify behaviors (both the person with dementia's and the Care Partner's) which are upsetting to the family. Care Partners will be taught to use an Activator, Behavior, Consequence (ABC) approach to identify activators of behaviors, the behaviors, and consequences of the behaviors. After they identify the ABCs, they will develop a plan to address the behavior and then test it. After the four one-to-one sessions, Care Partners will meet in small groups with a Guide. Effective communication strategies, engagement in pleasant events, and coping will be addressed.

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of Alzheimer's Disease and Related Dementias (ADRD), moderate to late stages
  • Exhibits 2 or more behaviors listed on Revised Memory and Behavioral Problems (RMBP) that are bothersome to the Care Partner and occur 3 or more times/week at study enrollment
  • Family member of Care Partner (this can be a relative, spouse or close kin that is considered family)

You may not qualify if:

  • Dementia not related to ADRD
  • Unable to leave Care Partner during Care Partner training
  • Early stage dementia, as defined by a Montreal Cognitive Assessment (MoCA) of about 15/30 or higher.
  • Adult caring for family member with ADRD
  • Lives with care recipient OR spends at least 4 hours/week with care recipient
  • Age of 18 years or older
  • Speak English
  • Own a computer/device with a reliable internet connection and compatible operating system
  • Unable to find activity for care recipient during training which would allow Care Partner to work privately, one-on-one during training
  • Completed similar telehealth intervention within the last year
  • Hearing and vision problems severe enough to prevent participation
  • Unwilling or unable to adequately follow study instructions and participate in study procedures
  • Participate in Oregon Roybal Center for CAre Support Translational Research Advantaged by Integrating Technology (ORCASTRAIT) (IRB#20236) Participant in the ORCASTRAIT study (IRB # 20236)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oregon Health and Science University, Layton Aging and Alzheimer's Disease Center

Portland, Oregon, 97239, United States

Location

Related Publications (1)

  • Dawson WD, Mattek N, Gothard S, Kaye J, Lindauer A. Ascertaining Out-of-Pocket Costs of Dementia Care: Feasibility Study of a Web-Based Weekly Survey. JMIR Form Res. 2024 Sep 25;8:e56878. doi: 10.2196/56878.

MeSH Terms

Conditions

DementiaAlzheimer DiseaseCaregiver Burden

Interventions

Educational Status

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental DisordersTauopathiesNeurodegenerative DiseasesStress, PsychologicalBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Socioeconomic FactorsPopulation Characteristics

Results Point of Contact

Title
Dr. Allison Lindauer
Organization
Oregon Health & Science University

Study Officials

  • Walter Dawson, PhD

    Oregon Health and Science University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 11, 2020

First Posted

April 6, 2020

Study Start

March 24, 2021

Primary Completion

June 1, 2023

Study Completion

June 15, 2023

Last Updated

January 23, 2024

Results First Posted

January 23, 2024

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will share

De-identified IPD will be available upon request to our Alzheimer's Disease Research Center.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Data will be available 1/2021, available indefinitely
Access Criteria
Requests need to made to the PI at the Oregon Alzheimer's Disease Research Center (OARDC). A short data request form will need to be submitted to the OADRC

Locations